Mandate

Vinge advises Oncopeptides in connection with a directed share issue

The board of directors of Oncopeptides has resolved on a directed new issue of shares, whereby Oncopeptides will raise proceeds of approximately SEK 727 million, before issue costs.

The share issue is directed to a number of selected international and Swedish reputable investors and life sciences specialist investors, on the basis of an accelerated bookbuilding process conducted by Carnegie Investment Bank AB (publ), Cowen, DNB Markets, a part of DNB Bank ASA, Jefferies International Limited and Kempen & CO N.V.

Oncopeptides is a clinical development pharmaceutical company focused on conducting anti-cancer research to develop treatments for the benefit of patients. The company’s shares are admitted to trading on Nasdaq Stockholm.

Vinge’s team has consisted of Dain Hård Nevonen, Sofie Bjärtun and Hampus Olsson.

Related

Vinge has advised Eleda in connection with the acquisition of Sartor & Drange AS

Vinge, together with Thommessen, advised the infrastructure group Eleda in connection with the acquisition of Sartor & Drange AS, a market-leading civil engineering contractor in the Bergen region. Sartor & Drange AS offers services in areas such as road, water and sewerage and foundation work in Western Norway. Sartor & Drange AS has approximately 200 employees and a turnover of approximately NOK 1,100 million.
June 17, 2024

Vinge has advised Svea Bank AB in connection with the issuance of callable tier 2 capital bonds (T2) of SEK 300 million

Vinge has advised Svea Bank AB in connection with its issuance of SEK 300 million callable tier 2 capital bonds (T2) with a floating rate interest of 3-month STIBOR + 6.75%. The issue date is set to 7 June 2024, and the bonds have a maturity of 10.25 years with first permitted redemption date after 5 years. The instruments will be listed on Nasdaq Stockholm.
June 14, 2024

Vinge advises Axcel and XPartners in connection with the acquisition of HTJ

Vinge has advised Axcel VII (“Axcel”) and XPartners Samhällsbyggnad (”XPartners”) in connection with the acquisition of HTJ Holding OY and its subsidiary Rakennuttajatoimisto HTJ Oy (”HTJ”).
June 13, 2024